Allspring Global Investments’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$466K	Buy	6,989 +646	+10%	+$41.1K	﹤0.01%	1407
2025 Q4	$392K	Buy	6,343 +679	+12%	+$42.2K	﹤0.01%	1438
2025 Q3	$316K	Buy	+5,664	New	+$233K	﹤0.01%	1467
2025 Q2	–	Sell	-5,763	Closed	-$216K	–	1664
2025 Q1	$216K	Sell	5,763 -78,258	-93%	-$3.6M	﹤0.01%	1646
2024 Q4	$4.11M	Sell	84,021 -9,278	-10%	-$482K	0.01%	983
2024 Q3	$4.93M	Buy	93,299 +5,487	+6%	+$306K	0.01%	948
2024 Q2	$4.76M	Buy	87,812 +84,396	+2,471%	+$5.09M	0.01%	969
2024 Q1	$239K	Buy	3,416 +558	+20%	+$43.2K	﹤0.01%	1671
2023 Q4	$239K	Sell	2,858 -1,644	-37%	-$59.5K	﹤0.01%	1657
2023 Q3	$133K	Sell	4,502 -20,534	-82%	-$684K	﹤0.01%	1898
2023 Q2	$817K	Sell	25,036 -174,881	-87%	-$6.47M	﹤0.01%	1464
2023 Q1	$7.04M	Buy	199,917 +6,157	+3%	+$251K	0.01%	895
2022 Q4	$8.88M	Buy	193,760 +1,405	+0.7%	+$60.5K	0.02%	810
2022 Q3	$9.32M	Buy	192,355 +6,462	+3%	+$311K	0.02%	800
2022 Q2	$7.3M	Sell	185,893 -31,055	-14%	-$1.25M	0.01%	871
2022 Q1	$7.99M	Sell	216,948 -1,381	-0.6%	-$49.1K	0.01%	965
2021 Q4	$9.95M	Buy	+218,329	New	+$8.42M	0.01%	922